(Total Views: 555)
Posted On: 01/17/2021 5:32:01 PM
Post# of 151003
Re: ClosetInvestor #73090
Leronlimab, with two 350mg SubQ injections at days 0 and 7 *may* be found to have a minimum mortality reduction in the 30% range.
700mg IV Leronlimab, administered at onset of immunologic dysfunction, likely will have nearly 100% mortality reduction.
It will be "part of" a multiprong strategy to combat CV19 until the other prongs fail due to viral mutation.. then it will be the sole savior.
700mg IV Leronlimab, administered at onset of immunologic dysfunction, likely will have nearly 100% mortality reduction.
It will be "part of" a multiprong strategy to combat CV19 until the other prongs fail due to viral mutation.. then it will be the sole savior.
(3)
(0)Scroll down for more posts ▼
